Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
QuantRX Biomedical Corp. (QTXB) had Income from Continuous Operations of $-0.06M for the most recently reported fiscal quarter, ending 2022-09-30.
| Income Statement Financials | |
-- |
|
$-0.06M |
|
-- |
|
-- |
|
$0.01M |
|
$-0.01M |
|
$-0.05M |
|
$-0.06M |
|
$-0.06M |
|
$-0.06M |
|
|
Income from Continuous Operations |
$-0.06M |
$-0.06M |
|
$-0.06M |
|
$-0.01M |
|
$-0.01M |
|
78.70M |
|
78.70M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$2.85M |
|
-- |
|
-- |
|
$2.85M |
|
$-2.90M |
|
$-2.84M |
|
$-2.84M |
|
78.70M |
|
| Cash Flow Statement Financials | |
$-0.03M |
|
-- |
|
$0.03M |
|
$0.01M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.11% |
|
2.15% |
|
-1136.28% |
|
2.15% |
|
$-0.04 |
|
$-0.00 |
|
$-0.00 |
|